For the Inventor, By the Inventor

Enter assignee name

Jacksonville, FL, United States of America

The Nemours Foundation

Calculating rank

USPTO Granted Patents = 45

% Expired Patents = 17.8

EPO Patents = 1

Trademarks = 15

Forward Citations = 1,224

Loading Chart...

Loading Chart...

48 inventors (with patents filed for the assignee):

Tariq Rahman (13 out of 14 patents)

Thomas H Shaffer (6 out of 28 patents)

Vicky L Funanage (6 out of 6 patents)

4. Gary Magram (6 out of 8 patents)

5. J Richard Bowen (5 out of 7 patents)

6. Whitney Sample (4 out of 4 patents)

7. Susan M Kirwin (4 out of 4 patents)

8. Marshall Z Schwartz (4 out of 4 patents)

9. Jinyong Wee (3 out of 3 patents)

10. Zhengyu Ma (2 out of 2 patents)

11. Neil Nghia Tran (2 out of 2 patents)

12. Jordan Wang (2 out of 2 patents)

13. Shunji Tomatsu (2 out of 14 patents)

14. Robert Akins (2 out of 6 patents)

15. Marcella Devoto (2 out of 2 patents)

Core Competencies:

Surgery Equipment

Cancer Treatment

Respiratory Assessment

Breast Pump Adapter

T-Cell Therapy

Wound Healing

Bone Density

Inflammatory Bowel Disease

Gastric Emptying

Orthosis Device

Medical Tubes

Eye Examination Kit

45 patents: Sort by Forward Citations

1. 12533277 - Head cradle for surgery (2026-01-27),

2. D1099310 - Breast pump hose adapter (2025-10-21),

3. 12383588 - Zika virus treatment of CD24-positive tumors and diseases associated with abnormal T cell activation and treating or preventing Zika virus infections (2025-08-12),

4. 12247213 - Treatment of mucopolysaccharidosis IVA (2025-03-11),

5. 11628239 - Method for protecting skeletonized blood vessels (2023-04-18),

6. 11484459 - Elbow flexion-assist appliance (2022-11-01),

7. 11384156 - Adoptive T-cell therapy using EMPD-specific chimeric antigen receptors for treating IgE-mediated allergic diseases (2022-07-12),

8. 11234640 - Non-invasive pulmonary function assessment and treatment of respiratory fatigue (2022-02-01),

9. 10195272 - Adoptive t-cell therapy using FcεRI-based chimeric antigen receptors for treating IgE-mediated allergic diseases (2019-02-05),

10. 10064614 - Depressor/retractor (2018-09-04),

11. 9982288 - Mucopolysaccharidosis IVA/VII screening and treatment method (2018-05-29),

12. 9687415 - Extrathoracic augmentation of the respiratory pump (2017-06-27),

13. D751197 - Retractor/depressor (2016-03-08),

14. 8835124 - Method for treating cancer with agents that bind phosphorylated CDC27 (2014-09-16),

15. 8771149 - Compliance monitor and method for a medical device (2014-07-08),

Company Overview

The Nemours Foundation is a prominent healthcare organization based in Jacksonville, Florida, dedicated to improving the health of children through innovative medical research and clinical care. It specializes in a range of advanced medical technologies and treatments, including solutions for mucopolysaccharidosis, adoptive T-cell therapy, and cancer treatment agents. The foundation also focuses on pulmonary function assessment and wound healing techniques, contributing significantly to pediatric healthcare advancements and addressing critical health challenges such as Zika virus treatment.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

45 Patents

#10 in Jacksonville, FL

#178 in Florida

#7,791 in US

#15,458 in the World

Jacksonville, FL, United States of America

The Nemours Foundation

Forward Citations = 1,224

48 inventors:

Tariq Rahman (13 out of 14 patents)

Thomas H Shaffer (6 out of 28 patents)

Vicky L Funanage (6 out of 6 patents)

4. Gary Magram (6 out of 8 patents)

5. J Richard Bowen (5 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: The Nemours Foundation. Retrieved from https://idiyas.com/company/nemours-foundation

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…